John M. Langstaff
Direktor/Vorstandsmitglied bei Therapure Biopharma, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bhupinder Brar | M | - |
Therapure Biopharma, Inc.
 Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | - |
| Lloyd Segal | M | 60 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 Jahre |
| Dirk Alkema | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 17 Jahre |
| Gabriel de Alba | M | 51 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 17 Jahre |
| Brian Harold Hadfield | M | 71 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | - |
| Ian Mumford | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 Jahre |
| Johan Vandersande | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 8 Jahre |
| Keith Tucker | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 7 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| R. Scott Lillibridge | M | 70 | - | |
| James Moodie Rae | M | - | 8 Jahre | |
| Michael Graham | M | - | 8 Jahre | |
| Andrew Storey | M | - | - | |
| Donald Bruce Burlington | M | 75 | - | |
| Francis J. St. Hilaire | M | - | - | |
| John Robert Lavery | M | - | - | |
| John A. Vivash | M | - | - | |
| Nicholas Green | M | 60 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 9 Jahre |
| R. Craig Baxter | M | 68 | - | |
| James Pasieka | M | 70 |
University of Manitoba
| 7 Jahre |
| Jacob M. Kay | M | 83 | - | |
| Philip R. Johnson | M | - | - | |
| Paul Brisebois | M | - | - | |
| Donald Hrap | M | 64 |
University of Manitoba
| 4 Jahre |
| Marvin Richardson | M | - |
University of Manitoba
| 4 Jahre |
| Paul Champagne | M | 65 |
University of Manitoba
| 4 Jahre |
| Brock J. Wright | M | 64 |
University of Manitoba
| 3 Jahre |
| Teck Lean Teong | M | 63 |
University of Manitoba
| 4 Jahre |
| Jim Dale | M | - |
University of Manitoba
| 4 Jahre |
| Edwin Mah | M | 63 |
University of Manitoba
| 4 Jahre |
| And Yeng Kheoh | F | 67 |
University of Manitoba
| 4 Jahre |
| Donald James Findlay | M | 77 |
University of Manitoba
| 1 Jahre |
| Larry Philip Fontaine | M | 80 |
University of Manitoba
| 4 Jahre |
| Brian Maynard | M | 64 |
University of Manitoba
| 4 Jahre |
| Sylvia Barnes | F | 67 |
University of Manitoba
| 4 Jahre |
| Kenneth Holmes | M | 68 |
University of Manitoba
| 3 Jahre |
| Bruce Warnock | M | - |
University of Manitoba
| 3 Jahre |
| Dwayne Car | M | - |
University of Manitoba
| 1 Jahre |
| Maxwell Polinsky | M | 66 |
University of Manitoba
| 4 Jahre |
| Doug Tkachuk | M | - |
University of Manitoba
| 3 Jahre |
| Ray Kohanik | M | - |
University of Manitoba
| 4 Jahre |
| Safa'a Al-Rais | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 11 Jahre |
| Shu Wing Liu | M | 68 |
University of Manitoba
| 4 Jahre |
| Eric Wallman | M | - |
University of Manitoba
| 4 Jahre |
| Sonia Tibbatts | F | 69 |
University of Manitoba
| 1 Jahre |
| Stanley Stewin | M | - |
University of Manitoba
| 4 Jahre |
| Dina Iezzi | F | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 11 Jahre |
| Raj Puri | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 10 Jahre |
| Trevor Young | M | - |
University of Manitoba
| 4 Jahre |
| Tai Hock Dang | M | 66 |
University of Manitoba
| 4 Jahre |
| David N. Bell | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 13 Jahre |
| Keith Wilford | M | - |
University of Manitoba
| 4 Jahre |
| Glen Hodgson | M | - |
University of Manitoba
| 3 Jahre |
| Chris Sinclair | M | - | - | |
| Gregory P. Downey | M | - |
University of Manitoba
| 4 Jahre |
| Robert Nickel | M | - |
University of Manitoba
| 4 Jahre |
| Les Deezar | M | - | - | |
| David Washenfelder | M | - |
University of Manitoba
| 4 Jahre |
| Donald Jeffrey Gawick | M | 66 |
University of Manitoba
| 4 Jahre |
| Laura Saward | M | - | 10 Jahre | |
| Peter K. Dorrins | M | - |
University of Manitoba
| 4 Jahre |
| Anatoly Langer | M | - |
University of Manitoba
| 3 Jahre |
| Wai Foon Tan | F | 65 |
University of Manitoba
| 4 Jahre |
| Jay M. Zammit | M | 64 |
University of Manitoba
| 4 Jahre |
| Glenn Asham | M | - |
University of Manitoba
| 4 Jahre |
| Brock Bulbuck | M | 64 |
University of Manitoba
| 4 Jahre |
| Alan Lowe | M | 62 |
University of Manitoba
| 4 Jahre |
| Ronald Mathison | M | 67 |
University of Manitoba
| 4 Jahre |
| Constantine Buzunis | M | 66 |
University of Manitoba
| 4 Jahre |
| Ernie Peter Friesen | M | - |
University of Manitoba
| 4 Jahre |
| John S. Pollard | M | 62 |
University of Manitoba
| 4 Jahre |
| Wayne S. Demkey | M | - |
University of Manitoba
| 4 Jahre |
| Bruce J. Hoeschen | M | - |
University of Manitoba
| 4 Jahre |
| Glen Clark Rattray | M | 61 |
University of Manitoba
| 4 Jahre |
| Michael Spino | M | - | - | |
| Claudio A. Ghersinich | M | 67 |
University of Manitoba
| 4 Jahre |
| Tom Bradley | M | - |
University of Manitoba
| 4 Jahre |
| Edward Sonshine | M | 77 | 1 Jahre | |
| Jeremy Curnock-Cook | M | 74 | 3 Jahre | |
| Donald Streuber | M | 66 |
University of Manitoba
| 4 Jahre |
| Brian D. Gordon | M | 67 |
University of Manitoba
| 3 Jahre |
| Bruce Mackenzie Rothney | M | - |
University of Manitoba
| 4 Jahre |
| Darrin Robert Drall | M | - |
University of Manitoba
| 4 Jahre |
| Gary W. Hayes | M | - |
University of Manitoba
| 4 Jahre |
| John Sanderson | M | 73 |
University of Manitoba
| 1 Jahre |
| David Cortens | M | - |
University of Manitoba
| 4 Jahre |
| Jeremy B. Desai | M | - | - | |
| Richard Thompson | M | 68 |
University of Manitoba
| 4 Jahre |
| David Stephen Cymbalisty | M | 60 |
University of Manitoba
| 4 Jahre |
| Warren Bates | M | - |
University of Manitoba
| 4 Jahre |
| Vicki Wolff-Long | M | - | - | |
| Newton G. Z. Glassman | M | 60 |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | - |
| Timothy Hodgson | M | 63 |
University of Manitoba
| 4 Jahre |
| Ronald Gregory Panchuk | M | 65 |
University of Manitoba
| 3 Jahre |
| Grant McClarty | M | - | 5 Jahre | |
| David A. Long | M | - |
Therapure Biopharma, Inc.
Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada. | 5 Jahre |
| Peter Gustavson | M | 67 |
University of Manitoba
| 4 Jahre |
| Don McDonald | M | - |
University of Manitoba
| 4 Jahre |
| Kenneth Hillier | M | 63 |
University of Manitoba
| 4 Jahre |
| Garnet Dawson | M | 66 |
University of Manitoba
| 4 Jahre |
| Gerry D. White | M | 68 |
University of Manitoba
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- John M. Langstaff
- Persönliches Netzwerk